Grifols completes refi as euro high yield grinds ever tighter
Spanish plasma drug group Grifols wrapped up an all-debt refinancing programme on Wednesday as high yield spreads continued to tighten. But market participants warned that terms can hardly become even more issuer-friendly.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: